阿奇霉素对小儿支原体肺炎的治疗效果与时间的相关性分析  

作　　者：林泽想[1] 王明义[1] 

机构地区：[1]广东江门市新会区人民医院儿科,529100

出　　处：《医学信息（下旬刊）》2011年第6期153-153,共1页Medical information

摘　　要：目的：探讨阿奇霉素治疗小儿支原体肺炎的最佳用药方法，提高临床治疗效果。方法：选取我院自2008年3月-2010年5月收治的120例支原体肺炎患儿随机分为观察组（序贯用药治疗组）和对照组（持续用药治疗组）各60例，比较两组患者的治疗效果。蛄果：①观察组患儿痊愈43例，显效15例，总有效率为96．7％；对照组患儿痊愈40例，显效17例，总有效率为96．7％。两组患儿比较无明显差异（P〉0．05），无统计学意义。②两组患儿病情好转情况无明显差异（P〉0．05），但住院时间、医疗费用方面比较两组差异显著（P〈0．01），具有统计学意义。③两组患儿不良反应发生率比较差异显著（P〈0．01），具有统计学意义。结论：采用阿奇霉素序贯疗法治疗小儿支原体肺炎效果理想，且具有良好的医疗经济学效应和临床用药安全性。Ohjective： To investigate the treatment of children with mycoplasma pneumonia azithromycin medication best ways to improve the clinical effect. Methods： In our hospital from March 2008 - May 2010 120 patients were treated mycoplasma pneumonia were randomly divided into two groups （sequential drug treatment group） and control group （continuous drug treatment group） of the 60 patients, comparing two group of patients treatment. Results： （1） study group 43 patients cured patients, effective in 15 cases, the total effective rate was 96.7% ; control group cured 40 eases of patients, effective in 17 cases, total effective rate was 96.7%. Children with no significant difference between the two groups （P〉 0.05）, not statistically significant. （2） two children with her condition improved and no significant difference （P〉 0.05）, but the length of hospital stay, medical cost differences between the two groups were significantly （P〈0.01）, with statistical significance. （3） The incidence of adverse reactions in children with the two groups was significant difference （P 〈0.01）, with statistical significance. Conclusion： Azithromycin sequential therapy of Mycoplasma pneumoniae results are satisfactory, and has good medical and economic effects of clinical drug safety.

关 键 词：阿奇霉素 小儿支原体肺炎 序贯治疗 

分 类 号：R725.6[医药卫生—儿科]